Genetic status of p53 and induction of apoptosis by radiation or isoflavones in human gastric carcinoma cell lines

International Journal of Oncology

Volumn 9, Issue 1, 1996, Pages 95-102

  Yanagihara, Kazuyoshi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

apoptosis; cell cycle arrest; gastric carcinoma; ionizing radiation; isoflavones

Indexed keywords

BIOCHANIN A; DAIDZEIN; GENISTEIN; ISOFLAVONE DERIVATIVE; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL SURVIVAL; DNA DAMAGE; GENE MUTATION; HUMAN; HUMAN CELL; IRRADIATION; PRIORITY JOURNAL;

EID: 0029999301     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.1.95     Document Type: Article

References (15)

1. Yamada Y, Yoshida T, Hayashi K, Sekiya T, Yokota J, Hirohashi S, Nakatani K, Nakano H, Sugimura T and Terada M: p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res 51: 5800-5805, 1991.
2. Matter R, Yokozaki H, Yasui W, Ito H and Tahara E: p53 gene mutations in gastric cancer cell lines. Oncology (Life Science Advances) 11:7-12, 1992.
3. Vogelstein B and Kinzler KW: p53 function and dysfunction. Cell 70: 523-526, 1992.
4. Lane DP: p53, guardian of the genome. Nature 358: 15-16, 1992.
5. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
6. Kuerbitz SJ, Plunkett BS, Walsh WV and Kasten MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495, 1992.
7. Zambetti GP and Levine AJ: A comparison of the biological activities of wild-type and mutant p53. FASEB J 7: 855-865, 1993.
8. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
9. Lowe SW, Ruley HE, Jacks T and Houseman DE: p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell 74: 957-967, 1993.
10. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852, 1993.
11. Radford IR: p53 status, DNA double-strand break repair proficiency, and radiation response of mouse lymphoid and myeloid cell lines. Int J Radiat Biol 66: 557-560, 1993.
12. Lee JM and Bernstein A: p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90: 5742-5746, 1993.
13. O'Connor P, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW: Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 53: 4776-4780, 1993.
14. Fan S, El-Deiry WS, Bac I, Freeman J, Jondle D, Bhatia K, Fornace AJ Jr, Magrath I, Kohn KW and O'Connor PM: p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824-5830, 1994.
15. Xia F, Wang X, Wang Y-H, Tsang N-M, Yandell DW, Kelsey KT and Liber HL: Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res 55: 12-15, 1995.